Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,362,931 | 1,281,790 | 1,465,158 | 1,936,194 | 1,834,534 |
| Marketable Securities | 68,620 | 15,330 | 355,446 | 301,400 | 285,575 |
| Receivables | 2,767,271 | 2,806,496 | 3,019,479 | 2,403,966 | 2,277,746 |
| Inventories | 1,952,115 | 1,844,269 | 1,686,860 | 1,397,290 | 1,323,926 |
| Other current assets | 176,282 | 116,740 | 84,344 | 66,308 | 62,826 |
| TOTAL | $6,327,219 | $6,064,625 | $6,611,286 | $6,105,158 | $5,784,607 |
| Non-Current Assets | |||||
| PPE Net | 2,129,580 | 2,032,941 | 2,056,764 | 1,954,278 | 1,851,668 |
| Investments And Advances | 210,592 | 0 | 0 | 0 | 0 |
| Intangibles | 4,365,639 | 4,298,184 | 4,371,377 | 4,284,703 | 4,059,734 |
| Other Non-Current Assets | 3,386,029 | 3,472,744 | 3,706,269 | 3,542,052 | 3,356,077 |
| TOTAL | $10,091,840 | $9,803,869 | $10,134,410 | $9,781,033 | $9,267,479 |
| Total Assets | $16,419,060 | $15,868,490 | $16,745,700 | $15,886,190 | $15,052,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,487,779 | 3,511,658 | 3,460,473 | 3,110,448 | 2,947,134 |
| Other current liabilities | 176,282 | 408,003 | 447,018 | 475,006 | 450,066 |
| TOTAL | $5,760,514 | $5,196,734 | $4,638,865 | $3,728,921 | $3,533,134 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,359,101 | 2,358,400 | 3,326,729 | 3,340,718 | 3,165,313 |
| Other Non-Current Liabilities | 946,986 | -1,179 | 1,627,820 | 1,628,765 | -16,400 |
| TOTAL | $3,990,596 | $3,920,840 | $4,967,803 | $4,983,950 | $4,722,268 |
| Total Liabilities | $9,751,110 | $9,117,574 | $9,606,668 | $8,712,871 | $8,255,402 |
| Shareholders' Equity | |||||
| Common Shares | 107,662 | 110,845 | 114,466 | 114,532 | 108,519 |
| Other shareholders' equity | 6,560,290 | 6,640,075 | 7,024,568 | 7,244,450 | 6,688,167 |
| TOTAL | $6,667,952 | $6,750,920 | $7,139,033 | $7,358,982 | $6,796,685 |
| Total Liabilities And Equity | $16,419,062 | $15,868,494 | $16,745,701 | $16,071,853 | $15,052,087 |